Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Oct;39(4):505–507. doi: 10.1136/gut.39.4.505

Bone disease after liver transplantation.

M S Losowsky 1, S H Hussaini 1
PMCID: PMC1383260  PMID: 8944556

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., NORDIN B. E., SHERLOCK S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med. 1956 Jul;25(99):299–312. [PubMed] [Google Scholar]
  2. Almdal T., Schaadt O., Vesterdad Jørgensen J., Lindgreen P., Ranek L. Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis. J Intern Med. 1989 Mar;225(3):207–213. doi: 10.1111/j.1365-2796.1989.tb00065.x. [DOI] [PubMed] [Google Scholar]
  3. Argao E. A., Balistreri W. F., Hollis B. W., Ryckman F. C., Heubi J. E. Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatology. 1994 Sep;20(3):598–603. [PubMed] [Google Scholar]
  4. Arnold J. C., Hauser D., Ziegler R., Kommerell B., Otto G., Theilmann L., Wüster C. Bone disease after liver transplantation. Transplant Proc. 1992 Dec;24(6):2709–2710. [PubMed] [Google Scholar]
  5. Bonkovsky H. L., Hawkins M., Steinberg K., Hersh T., Galambos J. T., Henderson J. M., Millikan W. J., Galloway J. R. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology. 1990 Aug;12(2):273–280. doi: 10.1002/hep.1840120214. [DOI] [PubMed] [Google Scholar]
  6. Compston J. E., Thompson R. P. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet. 1977 Apr 2;1(8014):721–724. doi: 10.1016/s0140-6736(77)92167-5. [DOI] [PubMed] [Google Scholar]
  7. Cvetkovic M., Mann G. N., Romero D. F., Liang X. G., Ma Y., Jee W. S., Epstein S. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation. 1994 Apr 27;57(8):1231–1237. doi: 10.1097/00007890-199404270-00016. [DOI] [PubMed] [Google Scholar]
  8. Davies M., Mawer E. B., Klass H. J., Lumb G. A., Berry J. L., Warnes T. W. Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3. Dig Dis Sci. 1983 Feb;28(2):145–153. doi: 10.1007/BF01315144. [DOI] [PubMed] [Google Scholar]
  9. Diamond T. H., Stiel D., Lunzer M., McDowall D., Eckstein R. P., Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology. 1989 Jan;96(1):213–221. [PubMed] [Google Scholar]
  10. Diamond T., Stiel D., Lunzer M., Wilkinson M., Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med. 1989 Mar;86(3):282–288. doi: 10.1016/0002-9343(89)90297-0. [DOI] [PubMed] [Google Scholar]
  11. Diamond T., Stiel D., Lunzer M., Wilkinson M., Roche J., Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 1990 Jan;31(1):82–87. doi: 10.1136/gut.31.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Diamond T., Stiel D., Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med. 1989 Mar 15;110(6):430–436. doi: 10.7326/0003-4819-110-6-430. [DOI] [PubMed] [Google Scholar]
  13. Dibble J. B., Sheridan P., Hampshire R., Hardy G. J., Losowsky M. S. Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease. Clin Endocrinol (Oxf) 1981 Oct;15(4):373–383. doi: 10.1111/j.1365-2265.1981.tb00677.x. [DOI] [PubMed] [Google Scholar]
  14. Dibble J. B., Sheridan P., Hampshire R., Hardy G. J., Losowsky M. S. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 1982;51(201):89–103. [PubMed] [Google Scholar]
  15. Eastell R., Dickson E. R., Hodgson S. F., Wiesner R. H., Porayko M. K., Wahner H. W., Cedel S. L., Riggs B. L., Krom R. A. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology. 1991 Aug;14(2):296–300. [PubMed] [Google Scholar]
  16. Epstein O., Kato Y., Dick R., Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr. 1982 Sep;36(3):426–430. doi: 10.1093/ajcn/36.3.426. [DOI] [PubMed] [Google Scholar]
  17. Floreani A., Chiaramonte M., Giannini S., Malvasi L., Lodetti M. G., Castrignano R., Giacomini A., D'Angelo A., Naccarato R. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. J Hepatol. 1991 Mar;12(2):217–223. doi: 10.1016/0168-8278(91)90941-4. [DOI] [PubMed] [Google Scholar]
  18. Guañabens N., Parés A., Mariñoso L., Brancós M. A., Piera C., Serrano S., Rivera F., Rodés J. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol. 1990 Oct;85(10):1356–1362. [PubMed] [Google Scholar]
  19. Haagsma E. B., Thijn C. J., Post J. G., Slooff M. J., Gips C. H. Bone disease after orthotopic liver transplantation. J Hepatol. 1988 Feb;6(1):94–100. doi: 10.1016/s0168-8278(88)80467-7. [DOI] [PubMed] [Google Scholar]
  20. Hawkins F. G., Leon M., Lopez M. B., Valero M. A., Larrodera L., Garcia-Garcia I., Loinaz C., Moreno Gonzalez E. Bone loss and turnover in patients with liver transplantation. Hepatogastroenterology. 1994 Apr;41(2):158–161. [PubMed] [Google Scholar]
  21. Hepner G. W., Roginsky M., Moo H. F. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976 Jul;21(7):527–532. doi: 10.1007/BF01464758. [DOI] [PubMed] [Google Scholar]
  22. Knapen M. H., Hamulyák K., Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med. 1989 Dec 15;111(12):1001–1005. doi: 10.7326/0003-4819-111-12-1001. [DOI] [PubMed] [Google Scholar]
  23. Krawitt E. L., Grundman M. J., Mawer E. B. Absorption, hydroxylation, and excretion of vitamin D3 in primary biliary cirrhosis. Lancet. 1977 Dec 17;2(8051):1246–1249. doi: 10.1016/s0140-6736(77)92660-5. [DOI] [PubMed] [Google Scholar]
  24. Lopez M. B., Gonzalez Pinto I., Hawkins F., Valero M. A., Leon M., Loinaz C., Garcia I., Gomez R., Moreno Gonzalez E. Effect of liver transplantation and immunosuppressive treatment on bone mineral density. Transplant Proc. 1992 Dec;24(6):3044–3046. [PubMed] [Google Scholar]
  25. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  26. Matloff D. S., Kaplan M. M., Neer R. M., Goldberg M. J., Bitman W., Wolfe H. J. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology. 1982 Jul;83(1 Pt 1):97–102. [PubMed] [Google Scholar]
  27. McCaughan G. W., Feller R. B. Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis. 1994 Jul-Aug;12(4):223–231. doi: 10.1159/000171456. [DOI] [PubMed] [Google Scholar]
  28. McDonald J. A., Dunstan C. R., Dilworth P., Sherbon K., Sheil A. G., Evans R. A., McCaughan G. W. Bone loss after liver transplantation. Hepatology. 1991 Oct;14(4 Pt 1):613–619. doi: 10.1016/0270-9139(91)90047-y. [DOI] [PubMed] [Google Scholar]
  29. Meys E., Fontanges E., Fourcade N., Thomasson A., Pouyet M., Delmas P. D. Bone loss after orthotopic liver transplantation. Am J Med. 1994 Nov;97(5):445–450. doi: 10.1016/0002-9343(94)90324-7. [DOI] [PubMed] [Google Scholar]
  30. Mitchison H. C., Bassendine M. F., Malcolm A. J., Watson A. J., Record C. O., James O. F. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology. 1989 Oct;10(4):420–429. doi: 10.1002/hep.1840100405. [DOI] [PubMed] [Google Scholar]
  31. Mitchison H. C., Malcolm A. J., Bassendine M. F., James O. F. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology. 1988 Feb;94(2):463–470. doi: 10.1016/0016-5085(88)90438-6. [DOI] [PubMed] [Google Scholar]
  32. Movsowitz C., Epstein S., Fallon M., Ismail F., Thomas S. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology. 1988 Nov;123(5):2571–2577. doi: 10.1210/endo-123-5-2571. [DOI] [PubMed] [Google Scholar]
  33. Paterson C. R., Losowsky M. S. The bones in chronic liver disease. Scand J Gastroenterol. 1967;2(4):293–300. doi: 10.3109/00365526709180085. [DOI] [PubMed] [Google Scholar]
  34. Reed J. S., Meredith S. C., Nemchausky B. A., Rosenberg I. H., Boyer J. L. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology. 1980 Mar;78(3):512–517. [PubMed] [Google Scholar]
  35. Reid I. R. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf) 1989 Jan;30(1):83–103. doi: 10.1111/j.1365-2265.1989.tb03730.x. [DOI] [PubMed] [Google Scholar]
  36. Rich G. M., Mudge G. H., Laffel G. L., LeBoff M. S. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant. 1992 Sep-Oct;11(5):950–958. [PubMed] [Google Scholar]
  37. Rico H. Alcohol and bone disease. Alcohol Alcohol. 1990;25(4):345–352. [PubMed] [Google Scholar]
  38. SUMMERSKILL W. H., KELLY P. J. Osteoporosis with fractures in anicteric cirrhosis: observations supplemented by microradiographic evaluation of bone. Proc Staff Meet Mayo Clin. 1963 Apr 24;38:162–174. [PubMed] [Google Scholar]
  39. Shane E., Rivas M. C., Silverberg S. J., Kim T. S., Staron R. B., Bilezikian J. P. Osteoporosis after cardiac transplantation. Am J Med. 1993 Mar;94(3):257–264. doi: 10.1016/0002-9343(93)90057-v. [DOI] [PubMed] [Google Scholar]
  40. Stellon A. J., Davies A., Compston J., Williams R. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. Gastroenterology. 1985 Nov;89(5):1078–1083. doi: 10.1016/0016-5085(85)90212-4. [DOI] [PubMed] [Google Scholar]
  41. Stellon A. J., Webb A., Compston J. E. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut. 1988 Mar;29(3):378–384. doi: 10.1136/gut.29.3.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stellon A. J., Webb A., Compston J., Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology. 1987 Jan-Feb;7(1):137–142. doi: 10.1002/hep.1840070127. [DOI] [PubMed] [Google Scholar]
  43. Stewart P. J., Stern P. H. Inhibition of parathyroid hormone and interleukin 1-stimulated bone resorption by cyclosporine A but not by cyclosporine H or F. Transplant Proc. 1988 Jun;20(3 Suppl 3):989–992. [PubMed] [Google Scholar]
  44. Thornton J. R., Triger D. R., Losowsky M. S. Variceal bleeding is associated with reduced risk of severe cholestasis in primary biliary cirrhosis. Q J Med. 1989 May;71(265):467–471. [PubMed] [Google Scholar]
  45. Van Berkum F. N., Beukers R., Birkenhäger J. C., Kooij P. P., Schalm S. W., Pols H. A. Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids. Gastroenterology. 1990 Oct;99(4):1134–1139. doi: 10.1016/0016-5085(90)90635-e. [DOI] [PubMed] [Google Scholar]
  46. Watson R. G., Coulton L., Kanis J. A., Lombard M., Williams R., Neuberger J., Elias E. Circulating osteocalcin in primary biliary cirrhosis following liver transplantation and during treatment with ciclosporin. J Hepatol. 1990 Nov;11(3):354–358. doi: 10.1016/0168-8278(90)90221-c. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES